A randomized double-blind phase III pivotal study of febuxostat (FEB) versus allopurinol (ALL) in the prevention of tumor lysis syndrome (TLS): Florence study.

Results

Naziv:	A randomized double-blind phase III pivotal study of febuxostat (FEB) versus allopurinol (ALL) in the prevention of tumor lysis syndrome (TLS): Florence study.
Autori :	Spina, Michele; ...; Ristic, Dusan J; ...; (broj, koautora 20)
Godina:	2014
Publikacija:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X Journal of Clinical Oncology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 32 br. 15 str. 9641-9641
DOI:	10.1200/jco.2014.32.15_suppl.9641
WoS-ID:	000358613204525
URI:	https://enauka.gov.rs/handle/123456789/808847
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

1
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Google Scholar^TM